Brian Carothers - Vice President and General Manager, Nucleic Acid Solutions Division, Agilent
Bio coming soon!
Whitney Herd – Vice President of Business Development, Sales, and Marketing
MBA, George Washington University; B.Sc. in Biology, University of Tennessee
Over 25 years of global leadership experience across biologics, vaccines, medical devices, and diagnostic instrumentation
Former senior commercial leader with Underwriters Laboratories and Grifols, directing business development and marketing for global life sciences portfolios
Brings deep expertise in strategic partnerships, global client engagement, and integrated commercial solutions for regulated manufacturing environments
Based in Northern Virginia and supporting customers worldwide
Andrew Mitchell - Associate Vice President of Business Development
Joined BioVectra in 2017 as the European Business Development Manager
Promoted to BioVectra’s Senior Director, Business Development in 2020
30 years of experience in the global pharmaceutical & fine chemical area
Experience in synthesis, and fermentation covering both CDMO and Generics industries
Worked with a number of organizations, with various specialized capabilities such as large scale chromatography, energetic chemistry, biocatalysis, high containment & microbial fermentation of small molecules
Normand Blais– Chief Science Officer
20+ years at GSK leading work on multiple vaccine programs
Recently held positions in industry include: Senior Director (Function Head) Protein Biochemistry; Director Antigen Design & Prototype Production; and, Lab Head, Antigen Design and Protein Characterization.
Key areas of expertise are:
Vaccinology and technical development of Biologics
Recombinant protein expression systems and purification
Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles production
Protein Engineering and Structural Biology
Leveraging and interpreting protein biophysical attributes and analytics
Post graduate studies in Functional Genomics (Université Laval) and Bioinformatics (MIT); M.Sc. Microbiology and Immunology (Laval).
Scott Doncaster - Vice President, Manufacturing, Technology & Engineering
B.Sc. in Biochemistry from Mount Allison University in 1990.
Worked towards a Masters program in Biochemistry at Queens University from 1991-1994.
Worked for the Hunter Group in Aurora, Ontario from 1994-1995 in developing and supervising high purity solvent distillation processes.
Joined BIOVECTRA in 1995, supervising the enzyme and natural products bioextraction processes.
Promoted to Operations Manager in 2000 and served in that position until 2003.
Served as capital project manager for the BIOVECTRA API facility in 2001-2002.
Took the position as Director of Operations for Atlantis BioActives in 2003 to oversee the capital installation, start-up and commercial extraction process for natural taxanes.
Promoted to Director of Manufacturing for BIOVECTRA in 2005.
Appointed to Vice President, Manufacturing Technologies & Engineering in 2014.
Valana Deighan - General Counsel
B.Sc. Degree from University of Prince Edward Island (2001).
LL.B. from University of New Brunswick (2004).
Admitted to Prince Edward Island Bar (2005).
Joined BIOVECTRA in 2005 as Associate General Counsel.
Appointed General Counsel in 2011.
Responsible for legal and corporate matters.
Kelly Merical - Agilent, Associate VP, Finance
25+ years’ experience in Agilent finance supporting various division and service organizations
Finance Director of Agilent’s CDMO Oligonucleotide division for 13 years through period of explosive growth and greenfield expansion
P&L responsibility and partner to executive team in developing long term strategies
Compliance, revenue recognition and integration lead
Over 25 years of global senior leadership experience in manufacturing operations, supply chain, and commercial management
Former General Manager at Catalent Pharma Solutions, overseeing multi-site operations with full P&L responsibility
Led major operational, quality, and efficiency improvements supporting biopharma and pharma customers worldwide
Previous executive roles with Roswell Textiles, Flex Ltd., and other multinational organizations, supporting large-scale manufacturing, technology transfer, and customer program execution
Brings extensive experience partnering with global life sciences companies to deliver reliable, high-quality manufacturing outcomes
Based in Canada and overseeing BIOVECTRA operations across Nova Scotia and Prince Edward Island
Mark Wellman - Vice President and General Manager, Complex Chemistry Operations
M.Sc. Degree from Memorial University of Newfoundland in 1996.
Over 20 years experience with BIOVECTRA over which time he has contributed as a team member towards the development of fine chemicals, advanced intermediates, and active pharmaceutical ingredients.
Held the positions of Research Scientist (1996), Product Manager (2001), Custom Synthesis Project Manager (2003) and Manufacturing Manager, Special Projects (2005). He has participated or successfully led several API manufacturing projects to completion.
Promoted to Director of Biotech Operations in 2009.
Appointed to Vice President, Manufacturing in 2014.
Appointed to Vice President & General Manager, Complex Chemistry in 2020.
Jeff Lay - Associate Vice President AMPD – Quality and Regulatory
Coming soon
Sean McCluskey - Vice President IT & Digitization
Electronics Engineering (Yorkville University)
Over 30 years of Experience in IT and Digital Product Development and Digital Platform Operations with Leading Canadian Media Brands
Over Twenty Years of Leadership Experience in IT Systems Development & Adoption
Specialization in Operational and Organizational Transformation and Digital Platform Development
SME Entrepreneur
Issam Ismaili - Associate Vice President Operations (Windsor, NS)
M.S. in Biotechnology, University of Wisconsin–Madison
Nearly 20 years of experience in biomanufacturing operations and production leadership at WuXi Advanced Therapies, Lonza, Catalent, and Roche
Experienced in advanced manufacturing across cell and gene therapy, mRNA, monoclonal antibodies, microbial fermentation, and viral vector platforms
Brings a proven track record of operational excellence and customer delivery in global CDMO environments
Fluent in English, French, and Arabic
Erfan Asif – Associate Vice President Quality/Regulatory
Appointed as Associate Vice President Quality/Regulatory in Biovectra in 2025.
Ph. D Degree in Pharmacognosy from University of Karachi and Heidelberg University, Germany in 1994.
30 years of experience in Pharmaceutical Industry in leadership role with Abbott Labs, MSD, Apotex, Ciba Vision, Pharmaceutical Solutions Industry, Sanofi etc.
Worked in different capacity as QA Manager (Abbott Labs) 1994, QC Manager (MSD) 1997, Validation Manager (Ciba Vision Sterile Mfg.) 2004, Quality Operations Head (PSI, Jeddah) 2012, Senior Technical Consultant (Sanofi) 2015.
Alex Joseph
– Associate Vice President, Engineering & Maintenance
Licensed professional engineer with more than 30 years of leadership experience in engineering, maintenance, and operations within regulated pharmaceutical and manufacturing environments
Former senior engineering leader at Trillium Healthcare Products, where he directed the company’s largest capital investment program and expanded manufacturing capacity by 50%
Proven track record delivering reliable, compliant, and efficient facility operations, including maintaining a 100% compliance record across multiple regulatory inspections
Experienced in building lean, operations-focused maintenance organizations that improve equipment uptime, reliability, and production continuity
Brings deep expertise supporting large-scale infrastructure, capital projects, and technical operations for global pharma and biotech customers
Based in Canada and leading engineering and maintenance across BIOVECTRA’s eight facilities in Nova Scotia and Prince Edward Island
SEO plus – Test
20+ years at GSK, leading R&D activities on multiple vaccine programs
Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
Key areas of expertise are:
Process development of protein Biologics/Recombinant Antigens
Recombinant protein expression (mammalian, insect, yeast, bacterial)
Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
Protein Engineering and Structural Biology
Defining quality attributes, biophysical characterization of proteins, and analytical strategy
Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).